m+Medelevator.RU
← Поиск публикаций
International journal of surgery case reports · 2026

Pseudomyogenic hemangioendothelioma of the tibia: a case report.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Takada Naoki, Oebisu Naoto, Yao Hana, Kohashi Kenichi, Terai Hidetomi

Аннотация

INTRODUCTION AND IMPORTANCE: Pseudomyogenic hemangioendothelioma (PMHE) is a rarely metastasizing intermediate endothelial neoplasm. It typically presents as multiple, discontinuous nodules in the lower extremities of young adult males. Most cases present skin or soft-tissue tumors, but intraosseous lesions without soft-tissue involvement are extremely rare. We report a case of PMHE of the tibia, diagnosed with FOSB staining.

PRESENTATION OF CASE: A 36-year-old man presented with pain in the lower left leg after exercise and at night. X-ray, SPECT/CT, and MRI revealed two discontinuous lytic lesions within the cortical bone of the left tibia. A curettage procedure was performed for biopsy, but a diagnosis could not be made for a long time. After further consultation, FOSB staining was positive in the nucleus, leading to a definitive diagnosis of PMHE. No recurrence or metastasis was observed 2 years after surgery.

CLINICAL DISCUSSION: PMHE is a rare endothelial tumor, and cases limited to bone without soft tissue involvement are exceptional. Diagnosis is difficult because of overlap with myogenic and epithelioid tumors, but nuclear FOSB staining is a reliable marker. Although local recurrence is frequent, metastasis is rare, underscoring the importance of accurate diagnosis and long-term follow-up.

CONCLUSION: This case highlights the importance of considering PMHE in the differential diagnosis of bone tumors, the utility of FOSB immunostaining in confirming the diagnosis, and the need for long-term follow-up given the high risk of local recurrence.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты